Prospective, randomized trial comparing short and long intravenous antibiotic treatment of acute pyelonephritis in children: Dimercaptosuccinic acid scintigraphic evaluation at 9 months

Pediatrics

Volumn 121, Issue 3, 2008, Pages

  Bouissou, Francois ^a,k   Munzer, Caroline ^a   Decramer, Stéphane ^a   Roussel, Bernard ^b   Novo, Robert ^c   Morin, Denis ^d   Lavocat, Marie Pierre ^e   Guyot, Claude ^f   Tacque, Sophie ^g   Fischbach, Michel ^h   Ouhayoun, Eric ⁱ   Loirat, Chantal ^j  

^a HÔPITAL DES ENFANTS   (France)

^b AMERICAN MEMORIAL HOSPITAL   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d HÔPITAL ARNAUD DE VILLENEUVE   (France)

^e UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^f Hopital Mere Enfant CHU de Nantes   (France)

^g RENNES UNIVERSITY HOSPITAL   (France)

^h HÔPITAL DE HAUTEPIERRE   (France)

ⁱ UNIVERSITÉ PAUL SABATIER   (France)

^j ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^k Néphrologle Pédiarrique   (France)

more..

Author keywords

Acute pyelonephritis; Antibiotics; Children; DMSA scinticiiaphy

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CEFTRIAXONE; NETILMICIN; SUCCIMER TC 99M; ANTIINFECTIVE AGENT; DIAGNOSTIC AGENT; SUCCIMER;

ACUTE PYELONEPHRITIS; ADOLESCENT; ARTICLE; BACTERIURIA; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE REGIMEN; DRUG EFFICACY; FEMALE; FEVER; HUMAN; KIDNEY SCAR; KIDNEY SCINTISCANNING; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SHORT COURSE THERAPY; ULTRASOUND; VESICOURETERAL REFLUX; ACUTE DISEASE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; DRUG ADMINISTRATION; DRUG COMBINATION; FOLLOW UP; HOSPITALIZATION; INFANT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FUNCTION TEST; PRESCHOOL CHILD; PROSPECTIVE STUDY; PYELONEPHRITIS; RISK; RISK ASSESSMENT; SCINTISCANNING; STATISTICAL MODEL; TIME; TREATMENT OUTCOME;

ACUTE DISEASE; ADOLESCENT; ANTI-BACTERIAL AGENTS; CEFTRIAXONE; CHILD; CHILD, PRESCHOOL; CONFIDENCE INTERVALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFUSIONS, INTRAVENOUS; KIDNEY FUNCTION TESTS; LOGISTIC MODELS; MALE; NETILMICIN; ODDS RATIO; PROSPECTIVE STUDIES; PYELONEPHRITIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SUCCIMER; TIME FACTORS; TREATMENT OUTCOME;

EID: 40949124815     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2006-3632     Document Type: Article

References (46)

1. Hellström A, Hanson E, Hansson S, Hjälmås K, Jodal U. Association between urinary symptoms at 7 years old and previous urinary tract infections. Arch Dis Child. 1991;66(2):232-234
2. Messi G, Peratoner L, Paduano L, et al. Epidemiology of urinary tract infection and vesicoureteral reflux in children. Helv Pae-diatr Acta. 19S9;43(5-6):389-396
3. Hoberman A, Chao HP, Keller D, Hickey R, Davis HW, Ellis D. Prevalence of urinary tract infection in febrile infants. J Pediatr. 1993;123(l):17-23
4. Jacobson S, Eklöf O, Lins LE, Wikstad I, Winberg J. Long-term prognosis of post-infectious renal scarring in relation to radiological findings in childhood: a 27-year follow-up. Pediatr Nephrol. 1992;6(l):19-24
5. Pistor K, Schärer K, Olbing H, Tamminen-Möbius T. Children with chronic renal failure in the Federal Republic of Germany: II-primary renal diseases, age and intervals from early renal failure to renal death. Clin Nephrol. 1985;23(6):278-284
6. Esbjörner E, Aronson S, Berg U, Jodal U, Linne T. Children with chronic renal failure in Sweden 1978-1985. Pediatr Nephrol. 1990;4(3):249-252
7. Lahdes-Vasama T, Niskanen K, Ronnholm K. Outcome of kidneys in patients treated for vesicoureteral reflux (VUR) during childhood. Nephrol Dial Transplant. 2006;21(9):2491-2497
8. Rushton HG, Majd M. Dimercaptosuccinic acid renal scintigraphy for the evaluation of pyelonephritis and scarring: a review of experimental and clinical studies. J Urol. 1992;I48(5 pt 2):1726-1732
9. Verboven M, Ingels M, Delree M, Piepsz A. 99m Tc-DMSA scintigraphy in acute urinary tract infection in children. Pediatr Radiol. 1990;20(7):540-542
10. Kass E, Fink-Bennett D, Cacciarelli A, Balon H, Pavlock S. The sensitivity of renal scintigraphy and sonography in detecting nonobstructive acute pyelonephritis. J Urol. 1992;148(2 pt 2): 606-608
11. Mackenzie JR. A review of renal scarring in children. Nucl Med Commun. 1996; 1.7 (3): 176-190
12. Majd M, Rushtion HG. Renal cortical scintigraphy in the diagnosis of acute pyelonephritis. Semin Nucl Med. 1992;22(2):98-111
13. Erb A, Stunner T, Marre R, Bremmer M. Prevalence of antibiotic resistance in Escherichia coli: overview of geographical, temporal, and methodological variations. Eur J Clin Microbiol Infect Dis. 2007;26(2):83-90
14. Bloomfield P, Hodson EM, Craig JC. Antibiotics for acute pyelonephritis in children. Cochrane Database Syst Rev. 2005;(1): CD003772
15. Ramage IJ, Bridges HG, Beattie TJ. An audit of the clinical management of urinary tact infection in childhood. Health Bull (Edinb). 1995;53(5):260-268
16. Bensman E, Leroy B. Treatment of urinary infection in children [in French]. Presse Med. 1993;22(38):1916-I920
17. Cornu C, Cochat P, Collet JP, Delair S, Haugh MC, Rolland C. Survey of the attitudes to management of acute pyelonephritis in children. Pediatr Nephrol. 1994;8(3):275-277
18. Levtchenko EN, Ham HR, Levy J, Piepsz A. Attitude of Belgian pediatricians toward strategy in acute pyelonephritis. Pediatr Nephrol. 2001;16(2): 113-115
19. Michael M, Hodson EM, Craig JC, Martin S, Mover VA. Short compared with standard duration of antibiotic treatment for urinary tract infection: a systematic review of randomised controlled trials. Arch Dis Child. 2002;87(2):118-123
20. Hoberman A, Wald ER, Hickey RW, et al. Oral versus initial intravenous therapy for urinary tract infections in young febrile children. Pediatrics. 1999;104(1 pt 1):127-129
21. Benador D, Neuhaus TJ, Papazyan J-P, et al. Randomised controlled trial of three day versus 10 day intravenous antibiotics in acute pyelonephritis: effect on renal scarring. Arch Dis Child. 2001;84(3):241-246
22. Vilaichone A, Watana D, Chaiwatanarat T. Oral ceftibuten switch therapy for acute pyelonephritis in children. J Med Assoc Thai. 2001;84(suppl l):61-67
23. Levtchenko E, Lahy C, Levy J, Ham H, Piepsz A. Treatment of children with acute pyelonephritis: a prospective randomized study. Pediatr Nephrol. 2001;16(11):878-884
24. Mackenzie JR. DMSA: the new "gold standard." Nucl Med Commun. 1990;11:725-726
25. Piepsz A, Hahn K, Roca I, et al. A radiopharmaceuticals schedule for imaging in paediatrics. Pediatric Task Group of the European Association in Nuclear Medicine. Eur J Nucl Med. 1990;17(3-4):127-129
26. Patel K, Charron M, Hoberman A, Brown ML, Rogers KD. Intra-and interobserver variability interpretation of DMSA scans using a set of standardized criteria. Pediatr Radiol. 1993; 23(7):506-509
27. Fleiss JL. Statistical Methods for Rates and Proportions. 2nd ed. New York, NY: Wiley; 1981:38-45
28. Wellek S, Michaelis J. Element of significance testing with equivalents problems. Methods Inf Med. 1991;30(3):194-198
29. Bouyer J. Logistic regression and epidemiology: I [in French]. Rev Epidemiol Sante Publique. 1991 ;39(l):79-87
30. Bouyer J. Logistic regression and epidemiology: II [in French]. Rev Epidemiol Sante Publique. 1991;39(2):183-196
31. Jakobsson B, Svensson L. Transient pyelonephritic changes on 99mTechnetium-dimercaptosuccinic acid scan for at least five months after infection. Acta Paediatr. 1997;86(8):803-807
32. Benador D, Benador N, Slosman D, Nussle D, Mermillod B, Girardin E. Cortical scintigraphy in the evaluation of renal parenchymal changes in children with pyelonephritis. J Pediatr. 1994;124(l):17-20
33. Craig WA. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis. 1998;26(1):1-10
34. Frimodt-Moller N. Correlation between pharmacokinetic/ pharmacodynamic parameters and efficacy for antibiotics in the treatment of urinary tract infection. Int J Atitimicrob Agents. 2002;19(6):546-553
35. Risdon RA, Yeung CK, Ransley PG. Reflux nephropathy in children submitted to unilateral nephrectomy: a clinicopatho-logical study. Clin Nephrol. 1993;40(6):308-3I4
36. Gordon I, Barkovics M, Pindoria S, Cole TJ, Woolf AS. Primary vesicoureteric reflux as a predictor of renal damage in children hospitalized with urinary tract infection: a systematic review and meta-analysis. J Am Soc Nephrol. 2003;14(3):739-744
37. Garin EH, Olavarria F, Nieto VG, Valenciano B, Campos A, Young L. Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study. Pediatrics. 2006; 117(3):626-632
38. Polito C, Rambaldi PF, Signoriello G, Mansi L, La Manna A. Permanent renal parenchymal defects after febrile UTI are closely associated with vesicoureteric reflux. Pediatr Nephrol. 2006;21(4):521-526
39. Chroustova D, Palyzova D, Urbanova I, Kolska M. Results of a five-year study of (99m)Tc DMSA renal scintigraphy in children and adolescents following acute pyelonephritis. Nucl Med Rev Cent East Eur. 2006;9(1 ):46-50
40. Sweeney B, Cascio S, Velayudham M, Puri P. Reflux nephropathy in infancy: a comparison of infants presenting with and without urinary tract infection. J Urol. 2001;166(2):648-650
41. Connolly LP, Treves ST, Connolly SA, et al. Vesicoureteral reflux in children: incidence and severity in siblings. J Urol. 1997;157(6):2287-2290
42. Ataei N, Madani A, Esfahani ST, et al. Screening for vesicoureteral reflux and renal scars in siblings of children with known reflux. Pediatr Nephrol. 2004;19( 10):1127-1131
43. Bonnin F, Lottmann H, Sauty L, et al. Scintigraphic screening for renal damage in siblings of children with symptomatic primary vesico-ureteric reflux. BJU Int. 2001;87(6):463-466
44. Taskinen S, Ronnholm K. Post-pyelonephritic renal scars are not associated with vesicoureteral reflux in children. J Urol. 2005;173(4):1345-1348
45. Glauser MP, Meylan P, Bille J. The inflammatory response and tissue damage. Pediatr Nephrol. 1987;! (4):615-622
46. O'Riordan E, Gross SS, Goligorsky MS. Technology Insight: renal proteomics-at the crossroads between promise and problems. Nat Clin Pract Nephrol. 2006;2(8):445-458